OR WAIT null SECS
February 11, 2022
China-based CDMO Asymchem acquires US-based chemical technology company Snapdragon.
February 10, 2022
Sartorius Stedim Biotech has completed the acquisition of the chromatography equipment division of Novasep.
The European Patent Office has granted another patent to Salipro Biotech, covering the composition-of-matter, methods, and uses of the company’s novel antigen technology.
February 07, 2022
The acquisition will include Rewrite’s DNA writing platform, expanding Intellia’s genome editing tools.
Bio-Rad’s four new antibodies will develop highly selective and sensitive assays for bioanalysis and drug monitoring of pertuzumab and its biosimilars.
Gandeeva raisded $40 million to advance its AI-driven cryo-EM platform, with which it will develop new therapeutics based on the precise imaging of protein–drug interactions.
February 04, 2022
Zetta Genomics has raised £2.5 million ($3.4 million) in new seed funding.
February 01, 2022
Arranta Bio will use Cytiva’s FlexFactory single-use manufacturing platform to produce mRNA vaccines.
Recipharm will build up its biologics service offering with the acquisition of GenIbet.
January 31, 2022
Metagenomi has successfully raised $175 million for use toward its research pipeline.